Erste Asset Management Gmb H C4 Therapeutics, Inc. Transaction History

Erste Asset Management Gmb H

  • $8.35 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 26, 2024
SELL
$1.81 - $3.89 $19,367 - $41,623
-10,700 Closed
0 $0
Q3 2022

Nov 26, 2024
BUY
$8.03 - $12.77 $85,921 - $136,639
10,700 New
10,700 $91.4 Million
Q2 2022

Nov 26, 2024
BUY
$5.06 - $26.46 $54,141 - $283,122
10,700 New
10,700 $78.5 Million
Q1 2022

Nov 22, 2024
BUY
$19.99 - $33.23 $213,892 - $355,560
10,700 New
10,700 $258 Million

Others Institutions Holding CCCC

# of Institutions
129
Shares Held
63.5M
Call Options Held
670K
Put Options Held
54.8K
View Full List

About C4 Therapeutics, Inc.

CCCC Quotes by TradingView
  • Ticker CCCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,913,800
  • Market Cap $164M
  • Description
  • C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...
More about CCCC
Track This Portfolio

Track Erste Asset Management Gmb H Portfolio

Follow Erste Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email